Discover an Optimized Standard
Built on the research and validation work of the EuroFlow™ Consortium* on the characterization of haematological malignancies for improved accurate diagnosis,1 the innovative BD OneFlow™ solution brings the standardization of leukaemia and lymphoma immunophenotyping one step forward, maximizing laboratory efficiency and enabling reliability and accuracy of results for clinical decisions and ultimately patient outcome.
*EuroFlow™ is a trademark of the EuroFlow Consortium
Unless otherwise noted, for In Vitro Diagnostic Use. CE marked to the European In Vitro Diagnostic Medical Device Directive 98/79/EC.
Not available for sale in the US.
1 J.J.M. van Dongen, L. Lhermitte, S. Böttcher, et al on behalf of the EuroFlow Consortium (EU-FP6, LSHB-CT-2006-018708). EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012, 26 (9): 1908-75.